The performance of companies tied to blockbuster drugs like Viagra presents a nuanced investment picture. While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key markets has introduced substantial volatility. Investors are now grappling with the effect of rival medications ,